BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 19578744)

  • 1. Human papillomavirus type 16 oncoprotein E7 suppresses cadherin-mediated cell adhesion via ERK and AP-1 signaling.
    Yuan H; Ito S; Senga T; Hyodo T; Kiyono T; Kikkawa F; Hamaguchi M
    Int J Oncol; 2009 Aug; 35(2):309-14. PubMed ID: 19578744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
    Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
    Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein.
    Kim SH; Oh JM; No JH; Bang YJ; Juhnn YS; Song YS
    Carcinogenesis; 2009 May; 30(5):753-7. PubMed ID: 19321801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A flow cytometry-based assay for the measurement of protein regulation of E-cadherin-mediated adhesion.
    Leong CM; Hibma MH
    J Immunol Methods; 2005 Jul; 302(1-2):116-24. PubMed ID: 15992814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of alpha2-antiplasmin inhibits E-cadherin processing mediated by the plasminogen activator/plasmin system, leading to suppression of progression of oral squamous cell carcinoma via upregulation of cell-cell adhesion.
    Hayashido Y; Hamana T; Ishida Y; Shintani T; Koizumi K; Okamoto T
    Oncol Rep; 2007 Feb; 17(2):417-23. PubMed ID: 17203182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16.
    Campo-Fernández B; Morandell D; Santer FR; Zwerschke W; Jansen-Dürr P
    J Virol; 2007 Jan; 81(2):1027-32. PubMed ID: 17093190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells.
    Suprynowicz FA; Disbrow GL; Krawczyk E; Simic V; Lantzky K; Schlegel R
    Oncogene; 2008 Feb; 27(8):1071-8. PubMed ID: 17704805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of squamous cell carcinoma antigen production by E-cadherin mediated cell-cell adhesion in squamous cell carcinoma cell line.
    Hirakawa H; Nawata S; Sueoka K; Murakami A; Takeda O; Numa F; Kato H; Sugino N
    Oncol Rep; 2004 Feb; 11(2):415-9. PubMed ID: 14719077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse relationship between E-cadherin and p27Kip1 expression in renal cell carcinoma.
    Migita T; Oda Y; Masuda K; Hirata A; Kuwano M; Naito S; Tsuneyoshi M
    Int J Oncol; 2008 Jul; 33(1):41-7. PubMed ID: 18575749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone increases expression of E-cadherin and claudin 4 in human pancreatic cancer cells.
    Kumei S; Motomura W; Yoshizaki T; Takakusaki K; Okumura T
    Biochem Biophys Res Commun; 2009 Mar; 380(3):614-9. PubMed ID: 19285010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor receptor-associated protein 1 regulates cell adhesion and synaptic morphology via modulation of N-cadherin expression.
    Kubota K; Inoue K; Hashimoto R; Kumamoto N; Kosuga A; Tatsumi M; Kamijima K; Kunugi H; Iwata N; Ozaki N; Takeda M; Tohyama M
    J Neurochem; 2009 Jul; 110(2):496-508. PubMed ID: 19490362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
    Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
    Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of e-cadherin-mediated homotypic adhesion of Caco-2 cells: a novel evaluation assay for peptide activities in modulating cell-cell adhesion.
    Kobayashi N; Ikesue A; Majumdar S; Siahaan TJ
    J Pharmacol Exp Ther; 2006 Apr; 317(1):309-16. PubMed ID: 16371447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins.
    Pozzi E; Basavecchia V; Zanotto C; Pacchioni S; Morghen Cde G; Radaelli A
    J Virol Methods; 2009 Jun; 158(1-2):184-9. PubMed ID: 19428588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells.
    Rincon-Orozco B; Halec G; Rosenberger S; Muschik D; Nindl I; Bachmann A; Ritter TM; Dondog B; Ly R; Bosch FX; Zawatzky R; Rösl F
    Cancer Res; 2009 Nov; 69(22):8718-25. PubMed ID: 19887612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM-CSF regulates fusion of mononuclear osteoclasts into bone-resorbing osteoclasts by activating the Ras/ERK pathway.
    Lee MS; Kim HS; Yeon JT; Choi SW; Chun CH; Kwak HB; Oh J
    J Immunol; 2009 Sep; 183(5):3390-9. PubMed ID: 19641137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroserpin regulates N-cadherin-mediated cell adhesion independently of its activity as an inhibitor of tissue plasminogen activator.
    Lee TW; Coates LC; Birch NP
    J Neurosci Res; 2008 May; 86(6):1243-53. PubMed ID: 18092357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lebectin increases N-cadherin-mediated adhesion through PI3K/AKT pathway.
    Sarray S; Siret C; Lehmann M; Marrakchi N; Luis J; El Ayeb M; André F
    Cancer Lett; 2009 Nov; 285(2):174-81. PubMed ID: 19501458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway.
    Liu WH; Chang LS
    Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation.
    Seo SH; Jin HT; Park SH; Youn JI; Sung YC
    Vaccine; 2009 Sep; 27(42):5906-12. PubMed ID: 19651174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.